|
1
|
Nanavaty P, Alvarez MS and Alberts WM:
Lung cancer screening: Advantages, controversies, and applications.
Cancer Control. 21:9–14. 2014. View Article : Google Scholar
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zappa C and Mousa SA: Non-small cell lung
cancer: Current treatment and future advances. Transl Lung Cancer
Res. 5:288–300. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yano T, Haro A, Shikada Y, Maruyama R and
Maehara Y: Non-small cell lung cancer in never smokers as a
representative ‘non-smoking-associated lung cancer’: Epidemiology
and clinical features. Int J Clin Oncol. 16:287–293. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hsu LH, Chu NM, Liu CC, Tsai SY, You DL,
Ko JS, Lu MC and Feng AC: Sex-associated differences in non-small
cell lung cancer in the new era: Is gender an independent
prognostic factor? Lung Cancer. 66:262–267. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Goldstraw P, Chansky K, Crowley J,
Rami-Porta R, Asamura H, Eberhardt WE, Nicholson AG, Groome P,
Mitchell A and Bolejack V; International Association for the Study
of Lung Cancer Staging and Prognostic Factors Committee, Advisory
Boards, and Participating Institutions; International Association
for the Study of Lung Cancer Staging and Prognostic Factors
Committee Advisory Boards and Participating Institutions. The IASLC
lung cancer staging project: Proposals for revision of the TNM
stage groupings in the forthcoming (eighth) edition of the TNM
Classification for lung cancer. J Thorac Oncol. 11:39–51. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rami-Porta R, Crowley JJ and Goldstraw P:
The revised TNM staging system for lung cancer. Ann Thorac
Cardiovasc Surg. 15:4–9. 2009.PubMed/NCBI
|
|
9
|
Oliveto S, Mancino M, Manfrini N and Biffo
S: Role of microRNAs in translation regulation and cancer. World J
Biol Chem. 8:45–56. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shivdasani RA: MicroRNAs: Regulators of
gene expression and cell differentiation. Blood. 108:3646–3653.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Felekkis K, Touvana E, Stefanou CH and
Deltas C: MicroRNAs: A newly described class of encoded molecules
that play a role in health and disease. Hippokratia. 14:236–240.
2010.
|
|
12
|
Xi Y, Nakajima G, Gavin E, Morris CG, Kudo
K, Hayashi K and Ju J: Systematic analysis of microRNA expression
of RNA extracted from fresh frozen and formalin-fixed
paraffin-embedded samples. RNA. 13:1668–1674. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
MacFarlane LA and Murphy PR: MicroRNA:
Biogenesis, function and role in cancer. Curr Genomics. 11:537–561.
2010. View Article : Google Scholar
|
|
14
|
Lan H, Lu H, Wang X and Jin H: MicroRNAs
as potential biomarkers in cancer: Opportunities and challenges.
Biomed Res Int. 2015:125094. 2015. View Article : Google Scholar
|
|
15
|
Paranjape T, Slack FJ and Weidhaas JB:
MicroRNAs: Tools for cancer diagnostics. Gut. 58:1546–1554. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Grady WM and Tewari M: The next thing in
prognostic molecular markers: MicroRNA signatures of cancer. Gut.
59:706–708. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Patnaik SK, Kannisto E, Knudsen S and
Yendamuri S: Evaluation of microRNA expression profiles that may
predict recurrence of localized stage I non-small cell lung cancer
after surgical resection. Cancer Res. 70:36–45. 2010. View Article : Google Scholar
|
|
18
|
Bishop JA, Benjamin H, Cholakh H, Chajut
A, Clark DP and Westra WH: Accurate classification of non-small
cell lung carcinoma using a novel microRNA-based approach. Clin
Cancer Res. 16:610–619. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li X, Shi Y, Yin Z, Xue X and Zhou B: An
eight-miRNA signature as a potential biomarker for predicting
survival in lung adenocarcinoma. J Transl Med. 12:1592014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chandran UR, Medvedeva OP, Barmada MM,
Blood PD, Chakka A, Luthra S, Ferreira A, Wong KF, Lee AV, Zhang Z,
et al: TCGA expedition: A data acquisition and management system
for TCGA data. PLoS One. 11:e01653952016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Barrett T, Wilhite SE, Ledoux P,
Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH,
Sherman PM, Holko M, et al: NCBI GEO: Archive for functional
genomics data sets-update. Nucleic Acids Res. 41:D991–D995. 2013.
View Article : Google Scholar
|
|
22
|
Yerukala Sathipati S and Ho SY:
Identifying the miRNA signature associated with survival time in
patients with lung adenocarcinoma using miRNA expression profiles.
Sci Rep. 7:75072017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Vucic EA, Thu KL, Pikor LA, Enfield KS,
Yee J, English JC, MacAulay CE, Lam S, Jurisica I and Lam WL:
Smoking status impacts microRNA mediated prognosis and lung
adenocarcinoma biology. BMC Cancer. 14:7782014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Becker-Santos DD, Thu KL, English JC,
Pikor LA, Martinez VD, Zhang M, Vucic EA, Luk MT, Carraro A,
Korbelik J, et al: Developmental transcription factor NFIB is a
putative target of oncofetal miRNAs and is associated with tumour
aggressiveness in lung adenocarcinoma. J Pathol. 240:161–172. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Rami-Porta R, Bolejack V, Giroux DJ,
Chansky K, Crowley J, Asamura H and Goldstraw P; International
Association for the Study of Lung Cancer Staging and Prognostic
Factors Committee, Advisory Board Members and Participating
Institutions. The IASLC lung cancer staging project: The new
database to inform the eighth edition of the TNM classification of
lung cancer. J Thorac Oncol. 9:1618–1624. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Peltier HJ and Latham GJ: Normalization of
microRNA expression levels in quantitative RT-PCR assays:
Identification of suitable reference RNA targets in normal and
cancerous human solid tissues. RNA. 14:844–852. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Qian X, Tan H, Zhang J, Zhuang X, Branch
L, Sanger C, Thompson A, Zhao W, Li KC, David L and Zhou X:
Objective classification system for sagittal craniosynostosis based
on suture segmentation. Med Phys. 42:5545–5558. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tan H, Bao J and Zhou X: A novel
missense-mutation-related feature extraction scheme for ‘driver’
mutation identification. Bioinformatics. 28:2948–2955. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cortes C and Vapnik V: Support-Vector
Networks. Mach Learn. 20:273–297. 1995. View Article : Google Scholar
|
|
30
|
You ZH, Yin Z, Han K, Huang DS and Zhou X:
A semi-supervised learning approach to predict synthetic genetic
interactions by combining functional and topological properties of
functional gene network. BMC Bioinformatics. 11:3432010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chang CC and Lin CJ: LIBSVM: A library for
support vector machines. ACM Trans Intell Syst Technol. 2011.
View Article : Google Scholar
|
|
32
|
Vlachos IS, Zagganas K, Paraskevopoulou
MD, Georgakilas G, Karagkouni D, Vergoulis T, Dalamagas T and
Hatzigeorgiou AG: DIANA-miRPath v3.0: Deciphering microRNA function
with experimental support. Nucleic Acids Res. 43:W460–W466. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Vlachos IS, Paraskevopoulou MD, Karagkouni
D, Georgakilas G, Vergoulis T, Kanellos I, Anastasopoulos IL,
Maniou S, Karathanou K, Kalfakakou D, et al: DIANA-TarBase v7.0:
Indexing more than half a million experimentally supported
miRNA:mRNA interactions. Nucleic Acids Res. 43:D153–D159. 2015.
View Article : Google Scholar :
|
|
34
|
Deng W, Wang Y, Liu Z, Cheng H and Xue Y:
HemI: A toolkit for illustrating heatmaps. PLoS One. 9:e1119882014.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Saito M, Schetter AJ, Mollerup S, Kohno T,
Skaug V, Bowman ED, Mathé EA, Takenoshita S, Yokota J, Haugen A and
Harris CC: The association of microRNA expression with prognosis
and progression in early-stage, non-small cell lung adenocarcinoma:
A retrospective analysis of three cohorts. Clin Cancer Res.
17:1875–1882. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Giangreco A, Groot KR and Janes SM: Lung
cancer and lung stem cells: Strange bedfellows? Am J Respir Crit
Care Med. 175:547–553. 2007. View Article : Google Scholar
|
|
37
|
Chaudhary K, Poirion OB, Lu L and Garmire
LX: Deep learning-based multi-omics integration robustly predicts
survival in liver cancer. Clin Cancer Res. 24:1248–1259. 2018.
View Article : Google Scholar
|
|
38
|
Han X, Du C, Chen Y, Zhong X, Wang F, Wang
J, Liu C, Li M, Chen S and Li B: Overexpression of miR-939-3p
predicts poor prognosis and promotes progression in lung cancer.
Cancer Biomark. 25:325–332. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Tang M, Jiang L, Lin Y, Wu X, Wang K, He
Q, Wang X and Li W: Platelet microparticle-mediated transfer of
miR-939 to epithelial ovarian cancer cells promotes epithelial to
mesenchymal transition. Oncotarget. 8:97464–97475. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang W, Li Y, Li X, Liu B, Han S, Li X,
Zhang B, Li J and Sun S: Circular RNA circ-FOXP1 induced by SOX9
promotes hepatocellular carcinoma progression via sponging
miR-875-3p and miR-421. Biomed Pharmacother. 121:1095172020.
View Article : Google Scholar
|
|
41
|
Ren Z, He M, Shen T, Wang K, Meng Q, Chen
X, Zhou L, Han Y, Ji C, Liu S and Fu Q: MiR-421 promotes the
development of osteosarcoma by regulating MCPIP1 expression. Cancer
Biol Ther. 21:231–240. 2020. View Article : Google Scholar
|
|
42
|
Wang W, Chen LC, Qian JY and Zhang Q:
MiR-335 promotes cell proliferation by inhibiting MEF2D and
sensitizes cells to 5-Fu treatment in gallbladder carcinoma. Eur
Rev Med Pharmacol Sci. 23:9829–9839. 2019.PubMed/NCBI
|
|
43
|
Geng Y, Zheng X, Hu W, Wang Q, Xu Y, He W,
Wu C, Zhu D, Wu C and Jiang J: Hsa circ 0009361 acts as the sponge
of miR-582 to suppress colorectal cancer progression by regulating
APC2 expression. Clin Sci (Lond). 133:1197–1213. 2019. View Article : Google Scholar
|
|
44
|
Jiang M, Shi L, Yang C, Ge Y, Lin L, Fan
H, He Y, Zhang D, Miao Y and Yang L: MiR-1254 inhibits cell
proliferation, migration, and invasion by down-regulating Smurf1 in
gastric cancer. Cell Death Dis. 10:322019. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Lunt SY and Fendt SM: Metabolism-A
cornerstone of cancer initiation, progression, immune evasion and
treatment response. Curr Opin Syst Biol. 8:67–72. 2018. View Article : Google Scholar
|
|
46
|
Chen B, Li H, Zeng X, Yang P, Liu X, Zhao
X and Liang S: Roles of microRNA on cancer cell metabolism. J
Transl Med. 10:2282012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Davidson SM, Papagiannakopoulos T,
Olenchock BA, Heyman JE, Keibler MA, Luengo A, Bauer MR, Jha AK,
O’Brien JP, Pierce KA, et al: Environment impacts the metabolic
dependencies of ras-driven non-small cell lung cancer. Cell Metab.
23:517–528. 2016. View Article : Google Scholar : PubMed/NCBI
|
